Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (9)

2007

  1. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis

    Rheumatology, Vol. 46, Núm. 3, pp. 431-434

2006

  1. Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide

    Reumatologia Clinica, Vol. 2, Núm. 3, pp. 137-145

  2. Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity [5]

    Annals of the Rheumatic Diseases

  3. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in Northwest Spain

    Journal of Rheumatology, Vol. 33, Núm. 2, pp. 285-288

2005

  1. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis

    Journal of Rheumatology, Vol. 32, Núm. 9, pp. 1737-1741

  2. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 32, Núm. 11, pp. 2178-2182

  3. Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in Northwestern Spain

    Journal of Rheumatology, Vol. 32, Núm. 6, pp. 1081-1085

  4. Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 32, Núm. 8, pp. 1510-1512

2004

  1. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain

    Rheumatology, Vol. 43, Núm. 9, pp. 1182-1185